Review of industrially recognized polymers and manufacturing processes for amorphous solid dispersion based formulations-Reference-Cited by-同舟云学术

Review of industrially recognized polymers and manufacturing processes for amorphous solid dispersion based formulations

Published:2023-07-14 Issue:7 Volume:28 Page:678-696
ISSN:1083-7450
Container-title:Pharmaceutical Development and Technology
language:en
Short-container-title:Pharmaceutical Development and Technology

Author:

Saha Sumit Kumar¹²^ORCID,Joshi Amita³^ORCID,Singh Romi²^ORCID,Dubey Kiran¹^ORCID

Affiliation:

1. Department of Pharmacology, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, India

2. Formulation Research and Development - Orals, Sun Pharmaceuticals Industries Limited, Gurugram, India

3. Biobay Solutions, Ahmedabad, India

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10837450.2023.2233595

Reference185 articles.

1. Aaron S, Deanna M. 2020. Considerations for the development of amorphous solid dispersions of poorly soluble drugs. CompareNetworks. [accessed 2023 Apr 15]. https://www.americanpharmaceuticalreview.com/.

2. Population Pharmacokinetic Modeling of Itraconazole and Hydroxyitraconazole for Oral SUBA-Itraconazole and Sporanox Capsule Formulations in Healthy Subjects in Fed and Fasted States

3. Characterization of Grades of HPMCAS Spray Dried Dispersions of Itraconazole Based on Supersaturation Kinetics and Molecular Interactions Impacting Formulation Performance

4. How to Improve Solubility and Dissolution of Irbesartan by Fabricating Ternary Solid Dispersions: Optimization and In-Vitro Characterization

5. Upscaling and in-line process monitoring via spectroscopic techniques of ethylene vinyl acetate hot-melt extruded formulations

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amorphous Solid Dispersions: Implication of Method of Preparation and Physicochemical Properties of API and Excipients;Pharmaceutics;2024-08-02

2. Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023;International Journal of Pharmaceutics: X;2024-06

3. Autism Spectrum Disorder: Brain Areas Involved, Neurobiological Mechanisms, Diagnoses and Therapies;International Journal of Molecular Sciences;2024-02-19